Clinical Trial Update: Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 study of pioglitazone in amyotrophic lateral sclerosis sponsored by the University of Ulm was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Ulm | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: TERMINATED